Cargando…
KH906, a recombinant human VEGF receptor fusion protein, is a new effective topical treatment for corneal neovascularization
PURPOSE: The purpose of the current study was to investigate the effect of topical administration of KH906 on corneal neovascularization (NV). METHODS: To induce corneal neovascularization, chemical cauterization of the corneas of the right eyes of forty-eight New Zealand white rabbits was performed...
Autores principales: | Li, Tao, Hu, Andina, Li, Shiqing, Luo, Yan, Huang, Juan, Yu, Honghua, Ma, Wei, Pan, Jianying, Zhong, Qi, Yang, Jin, Wu, Jianming, Tang, Shibo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081801/ https://www.ncbi.nlm.nih.gov/pubmed/21528000 |
Ejemplares similares
-
The inhibitory effect of different concentrations of KH902 eye drops on corneal neovascularization induced by alkali burn
por: Wu, Yan, et al.
Publicado: (2017) -
Treatment of Corneal Neovascularization Using Anti-VEGF Bevacizumab
por: Krizova, Deli, et al.
Publicado: (2014) -
Inhibition of Corneal Neovascularization by Topical and Subconjunctival Tigecycline
por: Goktas, Sertan, et al.
Publicado: (2014) -
Topical Timolol Inhibits Corneal Neovascularization in Rabbits
por: KASIRI, Ali, et al.
Publicado: (2017) -
Effects of VEGF Inhibitor Conbercept on Corneal Neovascularization Following Penetrating Keratoplasty in Rabbit Model
por: Liu, Huan, et al.
Publicado: (2020)